Dr. Blakely is the Director of the Center for Molecular Neuroscience and Allan D. Bass Chair in Pharmacology.  A Professor in the departments of Pharmacology and Psychiatry, he also serves as the Program Director of the Conte Center for Neuroscience Research at Vanderbilt.  For more information on his lab and general research interests, please see his laboratory’s website

In July of 2009, Dr. Levitt moved to the University of Southern California to serve as Director of the Zilkha Neurogenetic Institute, Provost Professor of Neuroscience, Psychiatry & Pharmacy, and Chair of the Department of Cell and Neurobiology.   For additional information on Dr. Levitt’s research interests, please review his website.

Dr. David Airey is a Research Professor of Pharmacology at Vanderbilt University Medical Center and is assuming the leadership role in the project formerly led by Dr. Elaine Sanders-Bush.  Dr. Airey was also one of the first recipients of the Conte Center Pilot Grants with his proposal on Htr2c RNA editing in hippocampus after stress.  To learn more about Dr. Airey and his research, please visit his website.

Dr. Emeson is a Professor in the departments of Pharmacology and Molecular Physiology & Biophysics and the Joel G. Hardman Chair in Pharmacology.  He has recently been appointed as the Deputy Director of the Center for Molecular Neuroscience and has been Director of the Vanderbilt Transgenic/ES Cell Shared Resource since 2003.  Additional information about Dr. Emeson and his research can be found on his website.

Dr. McMahon is a Professor in the Department of Biological Sciences at Vanderbilt University and a member of the Center for Molecular Neuroscience.  He is also the current Director of Graduate Studies in Biological Sciences.  For more comprehensive information about the ongoing research in the McMahon lab, please check out his website.

For more information on our consultants, please visit their page